ARVO 2022

Thanks for connecting to learn more about Syneos Health.

Connect with One of Our Experts

Laszlo Bekesi, MD MSc MBA Ophthalmologist,
Vice President Therapeutic Strategy and Innovation Neuroscience Group
Lori Helgeson, CPOT, ABOC, NCLC Executive Director,
Ophthalmology Clinical Development
Michael Botuchis, Senior Director, Business Development
Forest Flodin, Senior Director, Business Development
Alex Padgett, Associate Director, Business Development
Whitney Shankland, Senior Director, Business Development

We collaborate to restore vision and improve lives

Syneos Health has supported the development and commercialization of nearly 50 approved therapies for eye disorders, making us the leading provider of product development services for drug, device and diagnostics in vision care.

We always start with the end in mind

At Syneos Health, our unique lab-to-life service offering is purpose-built to provide you with integrated scientific, clinical, regulatory, commercialization and marketing expertise.

We bring commercial insights forward into clinical development with teams that combine traditional functions (i.e., project managers, medical monitors, CRAs and therapeutic and functional experts) with specialists in market access, study branding and patient engagement/advocacy, medical science liaisons and nurse educators.

詳細に興味がおありですか？ Explore Insights Hub for the latest industry perspectives, subscribe to our podcast, or click on the resources below:

Conducting Ophthalmology Clinical Trials During a Pandemic Outbreak

Ophthalmology Brochure